MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ABCL has $1,307,112K in assets. $369,029K in debts. $77,063K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1405.24%
Quick Ratio
1405.24%
Cash Ratio
162.94%
Debt to Asset Ratio
28.23%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Property and equipment, net
    • Other current assets
    • Others
Liabilities Breakdown
    • Common shares no par value, unli...
    • Additional paid-in capital
    • Operating lease liability
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
77,063 128,513 83,159 92,437
Marketable securities
427,669 405,313 412,513 460,641
Total cash, cash equivalents, and marketable securities
504,732 533,826 495,672 553,078
Accounts and accrued receivable
36,761 58,293 41,456 47,310
Restricted cash
25,000 25,000 25,000 25,000
Other current assets
98,103 111,113 133,012 116,757
Total current assets
664,596 728,232 695,140 742,145
Property and equipment, net
422,806 428,003 427,358 424,020
Gross carrying amount
69,320 69,320 91,133 -
Accumulated amortization
31,860 30,939 51,812 -
Intangible assets, net
37,460 38,381 39,321 40,262
Goodwill
47,806 47,806 47,806 47,806
Investments in equity accounted investees
65,308 62,580 93,301 90,374
Other long-term assets
69,136 51,948 53,066 57,454
Total long-term assets
642,516 628,718 660,852 659,916
Total assets
1,307,112 1,356,950 1,355,992 1,402,061
Accounts payable and other current liabilities
39,551 50,781 53,117 50,074
Contingent consideration payable
-0 0 0
Deferred revenue
7,743 13,526 15,687 16,949
Total current liabilities
47,294 64,307 68,804 67,023
Operating lease liability
134,309 137,403 137,052 137,184
Deferred tax liability
-9,115 9,744 10,053
Deferred revenue
--5,850 11,633
Deferred government contributions
176,105 174,453 169,118 167,532
Other long-term liabilities
11,321 4,768 1,386 1,560
Total long-term liabilities
321,735 325,739 323,150 327,962
Total liabilities
369,029 390,046 391,954 394,985
Common shares no par value, unlimited authorized shares at december31, 2025 and march31, 2026 300,600,710 and 303,945,581 shares issued and outstanding at december31, 2025 and march31, 2026, respectively
816,533 802,341 794,469 791,668
Additional paid-in capital
196,616 198,279 192,804 181,483
Accumulated other comprehensive loss
-2,419 -4,234 -2,698 -2,657
Accumulated deficit
-72,647 -29,482 -20,537 36,582
Total shareholders' equity
938,083 966,904 964,038 1,007,076
Total liabilities and shareholders' equity
1,307,112 1,356,950 1,355,992 1,402,061
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$427,669K Cash and cashequivalents$77,063K Gross carrying amount$69,320K Total cash, cashequivalents, and marketable...$504,732K Other current assets$98,103K Accounts and accruedreceivable$36,761K Restricted cash$25,000K Property and equipment,net$422,806K Other long-termassets$69,136K Investments in equityaccounted investees$65,308K Goodwill$47,806K Intangible assets, net$37,460K Accumulated amortization$31,860K Total current assets$664,596K Total long-termassets$642,516K Total assets$1,307,112K Total liabilities andshareholders' equity$1,307,112K Total shareholders'equity$938,083K Total liabilities$369,029K Accumulated deficit-$72,647K Accumulated othercomprehensive loss-$2,419K Common shares no parvalue, unlimited...$816,533K Additional paid-in capital$196,616K Total long-termliabilities$321,735K Total currentliabilities$47,294K Deferred governmentcontributions$176,105K Operating lease liability$134,309K Other long-termliabilities$11,321K Accounts payable andother current...$39,551K Deferred revenue$7,743K

AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Inc. (ABCL)